Cessatech Feed

	Est. tid*
2026-02-27	07:50	Bokslutskommuniké 2025
2025-11-13	08:30	Kvartalsrapport 2025-Q3
2025-08-21	-	Kvartalsrapport 2025-Q2
2025-05-15	-	Kvartalsrapport 2025-Q1
2025-03-31	-	X-dag ordinarie utdelning CESSA 0.00 DKK
2025-03-28	-	Årsstämma
2025-02-28	-	Bokslutskommuniké 2024
2024-11-13	-	Kvartalsrapport 2024-Q3
2024-08-21	-	Kvartalsrapport 2024-Q2
2024-05-15	-	Kvartalsrapport 2024-Q1
2024-03-28	-	X-dag ordinarie utdelning CESSA 0.00 DKK
2024-03-27	-	Årsstämma
2024-02-29	-	Bokslutskommuniké 2023
2023-11-16	-	Kvartalsrapport 2023-Q3
2023-08-24	-	Kvartalsrapport 2023-Q2
2023-05-12	-	Kvartalsrapport 2023-Q1
2023-03-24	-	X-dag ordinarie utdelning CESSA 0.00 DKK
2023-03-23	-	Årsstämma
2023-02-28	-	Bokslutskommuniké 2022
2022-11-18	-	Kvartalsrapport 2022-Q3
2022-11-04	-	Extra Bolagsstämma 2022
2022-08-19	-	Kvartalsrapport 2022-Q2
2022-04-19	-	Kvartalsrapport 2022-Q1
2022-03-18	-	X-dag ordinarie utdelning CESSA 0.00 DKK
2022-03-17	-	Årsstämma
2022-02-24	-	Bokslutskommuniké 2021
2021-11-19	-	Kvartalsrapport 2021-Q3
2021-08-19	-	Kvartalsrapport 2021-Q2
2021-04-19	-	Kvartalsrapport 2021-Q1
2021-03-29	-	X-dag ordinarie utdelning CESSA 0.00 DKK
2021-03-26	-	Årsstämma
2021-02-11	-	Bokslutskommuniké 2020

Land	Danmark
Lista	Spotlight DK
Sektor	Hälsovård
Industri	Bioteknik

2025-08-21 08:30:00 Cessatech: Second Quarter Report Q2-2025 11,76 DKK | -2,65% | 0,18 MDKK

2025-08-14 18:00:00 Cessatech: The Marketing Authorisation Application (MAA) for CT001 is submitted to the European Medicines Agency (EMA) for acute pain management in children 12,52 DKK | +9,25% | 0,70 MDKK

2025-06-27 13:31:25 Cessatech Q&A - June company presentation 11,74 DKK | -1,34% | 0,41 MDKK

2025-06-19 13:30:00 Cessatech strengthens Executive Management with the promotion of Martin Juhl 12,10 DKK | +7,08% | 0,30 MDKK

2025-06-11 14:15:00 Cessatech announce completion of the directed issue of shares 13,10 DKK | -5,21% | 0,45 MDKK

2025-05-28 22:30:00 Cessatech has carried out a directed share issue of approximately DKK 14.8 million to strengthen its financial position ahead of U.S. commercial launch

2025-05-28 17:30:00 Cessatech announces intention to carry out a directed share issue ahead of U.S. commercial launch

2025-05-28 17:15:00 Cessatech announces positive top-line results from its final CT001 Study 0202 13,46 DKK | +2,28% | 0,19 MDKK

2025-05-15 08:30:00 Cessatech: First Quarter Report Q1-2025 13,46 DKK | -4,67% | 0,48 MDKK

2025-04-30 15:45:00 Cessatech announces that recruitment has completed in the Paediatric Study 0202, and now the EMA submission process can be initiated for CT001 13,58 DKK | +4,14% | 0,26 MDKK

2025-03-28 11:30:00 Minutes from the Annual General Meeting in Cessatech A/S 8,72 DKK | -1,13% | 0,16 MDKK

2025-03-12 08:30:00 Cessatech: Annual General Meeting - 28 March 2025 9,48 DKK | +0,85% | 0,10 MDKK

2025-02-28 08:30:00 Cessatech A/S publishes Annual Report for the fiscal year 2024 11,45 DKK | -3,38% | 0,19 MDKK

2025-02-04 11:30:00 Cessatech receives positive Notified Body opinion under MDR for CT001 11,65 DKK | +6,88% | 0,72 MDKK

2024-12-23 12:00:00 Cessatech updates the milestones for the coming year 12,70 DKK | +8,09% | 0,33 MDKK

2024-11-13 13:00:00 Cessatech: Third Quarter Report Q3-2024 13,55 DKK | +0,37% | 0,41 MDKK

2024-10-16 10:00:00 Cessatech announces that recruitment has today reached the halfway point for patient recruitment with 75 included patients in the Paediatric Study 0202 15,05 DKK | -0,99% | 0,26 MDKK

2024-09-02 10:00:00 Cessatech and Proveca partnership - Q&A 11,90 DKK | 0,00% | 2,97 MDKK

2024-08-26 08:30:00 Cessatech and Proveca announce world-wide excluding US commercial partnership for CT001 8,76 DKK | +8,42% | 1,62 MDKK

2024-08-21 08:30:00 Cessatech: Second Quarter Report Q2-2024 7,88 DKK | +0,77% | 0,16 MDKK

2024-08-12 11:50:00 Cessatech extends its undrawn Loan Facility Agreement to DKK 10 million to support the forthcoming US launch of its lead program CT001 8,18 DKK | +3,54% | 0,12 MDKK

2024-08-02 15:00:00 Key Cessatech priorities for the rest of the year 8,00 DKK | +2,56% | 0,24 MDKK

2024-07-26 16:00:00 Cessatech: Grant of incentive warrants to Employees, CEO and the Board of Directors 7,14 DKK | +2,59% | 0,08 MDKK

2024-07-05 14:36:37 Cessatech announces changes to the Board of Directors 6,28 DKK | 0,00% | 0,03 MDKK

2024-07-05 14:31:18 Cessatech: Minutes of the Extraordinary General Meeting - 5 July 2024 6,28 DKK | 0,00% | 0,03 MDKK

2024-06-28 12:10:26 Cessatech presents new data on paediatric pain relief at the PAGE conference in Rome favouring its lead candidate CT001 6,28 DKK | +2,95% | 0,13 MDKK

2024-06-20 16:00:00 Cessatech: EXTRAORDINARY GENERAL MEETING 6,00 DKK | -2,91% | 0,11 MDKK

2024-06-03 13:00:00 Cessatech announces superior simulated pain efficacy in children favouring its lead candidate CT001 relative to its active comparators. 6,24 DKK | +4,35% | 0,22 MDKK

2024-05-27 14:53:40 Cessatech reports first patient dosed in final Safety Study 0202 of lead product candidate CT001 6,14 DKK | +2,68% | 0,11 MDKK

2024-05-15 08:45:00 Cessatech: First Quarter Report Q1-2024 5,94 DKK | -4,50% | 0,11 MDKK

2024-04-18 10:46:55 Cessatech: A short business update 6,30 DKK | +3,28% | 0,15 MDKK

2024-03-27 11:00:00 Minutes from the Annual General Meeting in Cessatech A/S 5,90 DKK | +3,51% | 0,22 MDKK

2024-03-11 17:00:00 Cessatech: Annual General Meeting - 27 March 2024 5,60 DKK | 0,00%

2024-02-29 09:00:00 Cessatech A/S publishes Annual Report for the fiscal year 2023 5,60 DKK | -5,08% | 0,19 MDKK

2024-01-30 08:30:00 Cessatech: CESSATECH ANNOUNCES RESULT OF WARRANT EXERCISE FOR WARRANTS OF SERIES TO2 6,30 DKK | +3,62% | 0,03 MDKK

2024-01-23 17:41:19 Cessatech: Correction: LAST DAY OF TRADING IN WARRANTS OF SERIES TO2 IN CESSATECH IS TOMORROW, JANUARY 24, 2024 6,04 DKK | +0,33% | 0,26 MDKK

2024-01-23 17:02:17 Cessatech: LAST DAY OF TRADING IN WARRANTS OF SERIES TO2 IN CESSATECH IS TOMORROW, JANUARY 24, 2024 6,02 DKK | -3,53% | 0,25 MDKK

2024-01-22 08:30:00 Cessatech: CESSATECH ANNOUNCES THAT MANAGEMENT AND BOARD HAVE EXERCISED ALL THEIR WARRANTS OF SERIES TO2 6,24 DKK | +1,30% | 0,23 MDKK

2024-01-12 08:00:00 Cessatech: CESSATECH ANNOUNCES THE START OF THE EXERCISE PERIOD FOR WARRANTS OF SERIES TO2 6,58 DKK | -0,30% | 0,72 MDKK

2024-01-11 08:00:00 Cessatech: CESSATECH ANNOUNCES TO2 WARRANT EXERCISE PRICE AND START OF EXERCISE PERIOD 6,60 DKK | -5,98% | 0,49 MDKK

2024-01-04 17:30:00 Cessatech: Q&A session related topline data Study 0205 6,08 DKK | +4,83% | 0,30 MDKK

2023-11-16 08:30:00 Cessatech: Third Quarter Report Q3-2023 4,09 DKK | -4,22% | 0,14 MDKK

2023-10-25 08:00:00 Cessatech announces that the Paediatric Committee has agreed to a 50% reduction of the required number of patients in the final study of its nasal spray for the treatment of acute pain in children 4,96 DKK | +6,90% | 0,12 MDKK

2023-09-21 13:55:51 Cessatech announces last participant dosed in pivotal trial 0205 with lead candidate CT001 4,00 DKK | -1,96% | 0,10 MDKK

2023-09-12 08:45:00 Cessatech announces agreement with the European Medicines Agency on a Paediatric Investigational Plan for its second asset CT002 for medical procedural sedation in children 5,00 DKK | +21,95% | 1,01 MDKK

2023-08-24 17:30:00 Cessatech: Second quarter report Q2-2023 1,89 DKK | +5,00% | 0,01 MDKK

2023-08-17 17:30:00 Cessatech secures DKK 5 million loan facility agreement to support the US launch of its lead program CT001 1,90 DKK | -1,30% | 0,00 MDKK

2023-06-30 08:58:43 Cessatech - Ventis Pharma US partnership - Q&A 1,90 DKK | +5,28% | 0,03 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Cessatech

Kalender

Beskrivning

Cessatech

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden